Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease who are eligible to receive the drug.
A new drug tested in a phase 3 trial showed significant improvement in patients with treatment-resistant ovarian cancer.
Post-traumatic osteoarthritis (PTOA) is a condition that affects joints after an injury. Current treatments focus on ...
For the study, the researchers gave the study participants an experimental anti-amyloid drug. They found that 22 participants ...
A team of pharmaceutical researchers at Novartis Biomedical Research, working with an international team of associates, has ...
9d
The Punch on MSNECOWAS renovates drug rehabilitation centre in KanoThe Economic Community of West African States has completed renovations at a drug treatment and rehabilitation centre located at the Aminu Kano Teaching Hospital in Kano State.This effort is part of ...
A hair loss drug that first gained popularity in the 1990s is seeing a resurgence of interest. Minoxidil is best known as the ...
“Every person working on it was let go,” Hoenig said, noting that the data collection is mandated by Congress. The office is ...
Not long ago, someone seeking withdrawal management at Fora Health risked being turned away due to lack of beds. Now, half ...
Staff didn’t realize 30-year-old Justin Cartwright died until the next day, according to his parents’ lawsuit.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results